Your browser doesn't support javascript.
loading
Development of measures of polyneuropathy impairment in hATTR amyloidosis: From NIS to mNIS + 7.
Dyck, P James B; González-Duarte, A; Obici, L; Polydefkis, M; Wiesman, J F; Antonino, I; Litchy, W J; Dyck, Peter J.
Affiliation
  • Dyck PJB; Department of Neurology, Mayo Clinic, Rochester, MN, USA. Electronic address: Dyck.PJames@mayo.edu.
  • González-Duarte A; Department of Neurology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, México D.F., Mexico.
  • Obici L; Amyloidosis Research and Treatment Center, Foundation IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy.
  • Polydefkis M; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Wiesman JF; Department of Neurology, Boston University School of Medicine, Boston, MA, USA.
  • Antonino I; Alnylam Pharmaceuticals, Cambridge, MA, USA.
  • Litchy WJ; Department of Neurology, Mayo Clinic, Rochester, MN, USA.
  • Dyck PJ; Department of Neurology, Mayo Clinic, Rochester, MN, USA.
J Neurol Sci ; 405: 116424, 2019 Oct 15.
Article in En | MEDLINE | ID: mdl-31445300
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polyneuropathies / Amyloid Neuropathies, Familial / Symptom Assessment Limits: Humans Language: En Journal: J Neurol Sci Year: 2019 Document type: Article Country of publication: Países Bajos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polyneuropathies / Amyloid Neuropathies, Familial / Symptom Assessment Limits: Humans Language: En Journal: J Neurol Sci Year: 2019 Document type: Article Country of publication: Países Bajos